Novo Integrated Sciences Wholly Owned Canadian Subsidiary, Acenzia, Selected To Participate In Protein Industries Canada Program To Develop Plant Based Protein Products; Project Investment Amounts Expected To Total $5.4M With Acenzia Investing $600K,...
Novo Integrated Sciences Wholly Owned Canadian Subsidiary, Acenzia, Selected To Participate In Protein Industries Canada Program To Develop Plant Based Protein Products; Project Investment Amounts Expected To Total $5.4M With Acenzia Investing $600K,...
Novo Integrated Sciences Wholly Owned Canadian Subsidiary, Acenzia, Selected To Participate In Protein Industries Canada Program To Develop Plant Based Protein Products; Project Investment Amounts Expected To Total $5.4M With Acenzia Investing $600K, Protein Industries Canada Investing $2.3M, And Two Other Partner Companies Investing $2.5M
Novo Integrated Sciences完全擁有的加拿大子公司Acenzia被選中參加蛋白質工業加拿大計劃，開發植物性蛋白製品。項目投資金額預計將達到540萬美元，其中Acenzia投資60萬美元，蛋白質工業加拿大投資230萬美元，另外兩家合作伙伴公司投資250萬美元。
Project investment amounts expected to total $5.4 million with Acenzia investing $600 thousand, Protein Industries Canada investing $2.3 million, and two other partner companies investing $2.5 million
項目投資金額預計爲540萬美元，其中Acenzia投資60萬美元，Protein Industries Canada投資230萬美元，另外兩家合作伙伴公司投資250萬美元。
Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") announced today that its wholly owned Canadian subsidiary, Acenzia Inc. ("Acenzia"), has been selected by Protein Industries Canada to participate in a new project to bring new protein products with a superior nutritional amino acid profile to the global marketplace. The total project is expected to see approximately $5.4 million invested into the development, reformulation, and commercialization of three consumer-ready protein products: a modular, a ready-to-mix and a ready-to-drink low-volume liquid protein. Acenzia will invest approximately $600,000, Protein Industries Canada will invest approximately $2.3 million, and two other partner companies together will invest approximately $2.5 million over three defined phases.
Novo Integrated Sciences, Inc.(NASDAQ:NVOS)(“公司”或“Novo”)今天宣佈，其全資擁有的加拿大子公司Acenzia Inc.(“Acenzia”)已被蛋白質工業加拿大選中參加一項新項目，推出一系列具有優秀營養氨基酸組合比例的新蛋白質產品進入全球市場。該項目總投資預計約爲540萬美元，用於開發、改進和商業化三種消費者即食膳食補充蛋白質產品：模塊化產品、即可混合產品和即飲型低容積液體蛋白質。Acenzia將投資約60萬美元，蛋白質工業加拿大將投資約230萬美元，另外兩家合作伙伴公司將聯合投資約250萬美元，跨越三個定義的階段。
The project partners are utilizing innovative solutions to offer alternative plant-based protein options that meet the quality, sensory and muscle health benefits of whey protein isolate.
項目合作伙伴正在利用創新解決方案，提供滿足乳清分離蛋白的品質、感官和肌肉健康益處的另類植物蛋白選項。
譯文內容由第三人軟體翻譯。